書誌事項
- タイトル別名
-
- Unrelated or mismatched related donor stem cell transplantation for myeloid malignancies with a fludarabine- and busulfan-based reduced-intensity conditioning regimen
この論文をさがす
説明
type:text
Many patients with myeloid malignancies are ineligible for conventional allogeneic hematopoietic stem cell transplantation (allo-HSCT) with myeloablative conditioning because of their age, medical problems, or the lack of a suitable HLA-identical related donor. The outcome of 9 patients with myeloid malignancies who underwent allo-HSCT following fludarabine- and busulfan- based reduced intensity conditioning (RIC) from unrelated or mismatched related donor is herein described. Six patients received bone marrow from an unrelated donor, two received a serologically mismatched related allograft, and one received serologically mismatched unrelated cord blood. All patients demonstrated successfully engraftment at a median of 15 days and showed complete donor chimerism of 9527772566420n day 28. One patient developed grade 3 regimen-related toxicity. Grade II to IV acute graft-versus-host disease (GVHD) and extensive type chronic GVHD developed in 6 and 4 patients, respectively. Of the two patients who received the second HSCT, one died of relapse and one died of acute GVHD. The remaining 7 patients are currently alive in remission. The overall survival at 4 years after allo-HSCT was 77.8%.0 These observations suggest that these RIC regimens enable rapid engraftment of stem cells from alternative donors with tolerable toxicities in patients who are not eligible for conventional HSCT.
収録刊行物
-
- 千葉医学雑誌 = Chiba medical journal
-
千葉医学雑誌 = Chiba medical journal 84 (3), 127-135, 2008-06-01
The Chiba Medical Society
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390853647794975616
-
- NII論文ID
- 10026993564
-
- NII書誌ID
- AN00142148
-
- ISSN
- 03035476
-
- NDL書誌ID
- 9557744
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- IRDB
- NDL
- CiNii Articles